Investor Kirk Randal J
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kirk Randal J . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-09-19 13D/A PGEN / Precigen, Inc. 116,844,357 146,295,359
2024-12-30 13D/A PGEN / Precigen, Inc. 116,844,357 116,844,357
2024-08-13 13D/A PGEN / Precigen, Inc. 93,314,946 116,844,357
2024-05-03 13D/A PGEN / Precigen, Inc. 96,360,443 93,314,946
2023-06-30 13D/A AQB / AquaBounty Technologies, Inc. 4,485,302 3,493,643
2023-06-07 13D/A AQB / AquaBounty Technologies, Inc. 5,344,002 4,485,302
2023-01-31 13D/A PGEN / Precigen, Inc. 84,805,277 96,360,443
2022-10-07 13D/A PGEN / Precigen, Inc. 81,822,163 84,805,277
2021-11-24 13D/A AQB / AquaBounty Technologies, Inc. 18,219,824 5,344,002
2020-12-21 13D/A AQB / AquaBounty Technologies, Inc. 18,253,912 18,219,824
2020-12-21 13D/A PGEN / Precigen, Inc. 84,000,000 81,822,163
2020-10-08 13D/A OGEN / Oragenics, Inc. 4,612,166 230,792
2020-08-13 13D/A PGEN / Precigen, Inc. 81,523,936 84,000,000
2020-08-13 13D/A AQB / AquaBounty Technologies, Inc. 14,251,753 18,253,912
2020-03-02 13D/A OGEN / Oragenics, Inc. 4,612,166
2020-02-18 13D/A AQB / AquaBounty Technologies, Inc. 9,076,753 14,251,753
2020-02-04 13D/A PGEN / Precigen, Inc. 81,523,936
2020-01-06 13D/A PGEN / Precigen, Inc. 74,378,292
2019-11-05 13D/A HALO / Halozyme Therapeutics, Inc. 10,544,241 7,046,385
2019-10-31 13D/A AQB / AquaBounty Technologies, Inc. 9,076,753 9,076,753
2019-09-17 13D/A FCSC / Fibrocell Science Inc. 10,994,686
2019-07-03 13D/A HALO / Halozyme Therapeutics, Inc. 12,111,874 10,544,241
2019-06-10 13D/A PGEN / Precigen, Inc. 72,179,353 74,378,292
2019-06-07 13D/A HALO / Halozyme Therapeutics, Inc. 14,092,771 12,111,874
2019-05-28 13D/A PGEN / Precigen, Inc. 72,179,353 72,179,353
2019-05-24 13D/A PGEN / Precigen, Inc. 70,439,882 72,179,353
2019-05-15 13D/A PGEN / Precigen, Inc. 66,789,237 70,439,882
2019-04-03 13D/A SYN / Synthetic Biologics Inc 13,238,268 227,674
2019-01-15 13D/A OCGN / Ocugen, Inc. 1,692,366
2018-12-12 13D/A ZIOP / Alaunos Therapeutics Inc 7,962,377
2018-10-29 13D/A AQB / AquaBounty Technologies, Inc. 9,076,753 9,076,753
2018-10-15 13D/A ZIOP / Alaunos Therapeutics Inc
2018-09-14 13D/A PRPO / Precipio, Inc. 1,140,019
2018-09-14 13D/A PRPO / Precipio, Inc. 1,768,915 1,140,019
2018-08-28 13D/A HALO / Halozyme Therapeutics, Inc. 15,922,747 14,092,771
2018-08-16 13D/A HALO / Halozyme Therapeutics, Inc. 17,592,771 15,922,747
2018-07-06 13D/A PGEN / Precigen, Inc. 58,928,289 66,789,237
2018-01-22 13D/A PGEN / Precigen, Inc. 57,928,289 58,928,289
2018-01-19 13D/A AQB / AquaBounty Technologies, Inc. 5,999,831 9,076,753
2018-01-02 13D/A PGEN / Precigen, Inc. 57,928,289
2017-12-13 13D/A FCSC / Fibrocell Science Inc. 10,994,686
2017-11-13 13D/A OGEN / Oragenics, Inc. 15,481,644
2017-10-23 13D/A PGEN / Precigen, Inc. 56,223,681
2017-09-05 13D/A PRPO / Precipio, Inc. 1,768,915
2017-09-05 13D/A PRPO / Precipio, Inc. 1,356,896 1,768,915
2017-07-26 13D/A AQB / AquaBounty Technologies, Inc. 6,091,777 5,999,831
2017-07-26 13D/A HALO / Halozyme Therapeutics, Inc. 19,315,403 17,592,771
2017-07-26 13D/A PGEN / Precigen, Inc. 61,877,273 56,223,681
2017-07-03 13D/A PRPO / Precipio, Inc. 1,356,896
2017-07-03 13D/A PRPO / Precipio, Inc. 6,040,374 1,356,896
2017-06-16 13D/A SNGX / Soligenix, Inc. 359,361 277,631
2017-06-12 13D/A PRPO / Precipio, Inc. 6,040,374
2017-06-12 13D/A PRPO / Precipio, Inc. 6,040,374
2017-05-26 13D/A SNGX / Soligenix, Inc. 448,700 359,361
2017-05-18 13D/A SNGX / Soligenix, Inc. 525,815 448,700
2017-05-08 13D/A SNGX / Soligenix, Inc. 525,815
2017-04-11 13D/A PRPO / Precipio, Inc.
2017-04-11 13D/A PRPO / Precipio, Inc. 8,464,848
2017-03-10 13D/A FCSC / Fibrocell Science Inc.
2017-01-20 13D AQB / AquaBounty Technologies, Inc. 6,091,777
2016-12-30 13D/A APHB / Ampliphi Biosciences Corp. 176,840
2016-11-16 13D/A APHB / Ampliphi Biosciences Corp.
2016-09-09 13D/A FCSC / Fibrocell Science Inc. 16,620,414
2016-07-06 13D/A ZIOP / Alaunos Therapeutics Inc 9,690,063
2016-07-05 13D/A OGEN / Oragenics, Inc. 13,220,225 15,481,644
2016-06-02 13D/A PGEN / Precigen, Inc. 61,877,273
2016-06-02 13D/A HALO / Halozyme Therapeutics, Inc. 19,315,403
2016-04-15 13D/A APHB / Ampliphi Biosciences Corp. 84,725,104
2016-01-12 13D/A PRPO / Precipio, Inc. 8,464,848
2016-01-12 13D/A PRPO / Precipio, Inc. 8,464,848
2015-12-03 13D/A OGEN / Oragenics, Inc. 13,220,225
2015-09-04 13D/A SYN / Synthetic Biologics Inc 13,238,268
2015-07-27 13D/A FCSC / Fibrocell Science Inc. 16,620,414
2015-06-09 13D/A ZIOP / Alaunos Therapeutics Inc 9,690,063
2015-03-20 13D APHB / Ampliphi Biosciences Corp. 84,725,104
2015-02-13 13G APHB / Ampliphi Biosciences Corp. 70,785,712
2015-02-10 13D/A ZIOP / Alaunos Therapeutics Inc 19,297,415
2015-01-05 13D/A PGEN / Precigen, Inc. 61,180,554
2014-12-10 13D OCGN / Ocugen, Inc. 2,690,570
2014-04-07 13D PGEN / Precigen, Inc. 62,578,335
2014-03-07 13D/A PRPO / Precipio, Inc. 3,901,561
2014-01-28 13D/A FCSC / Fibrocell Science Inc. 15,244,427
2013-12-30 13D 12,066,218
2013-12-26 13D/A OGEN / Oragenics, Inc. 9,839,221
2013-12-19 13D/A SYN / Synthetic Biologics Inc 12,300,768
2013-11-22 13D/A OGEN / Oragenics, Inc. 9,140,980
2013-10-31 13D/A ZIOP / Alaunos Therapeutics Inc 17,813,557
2013-10-03 13D/A FCSC / Fibrocell Science Inc. 14,219,837
2013-10-02 13D/A OGEN / Oragenics, Inc. 7,898,490
2013-07-30 13D/A FCSC / Fibrocell Science Inc. 10,561,301
2013-06-26 13D/A SNGX / Soligenix, Inc. 6,867,816
2013-05-09 13D SNGX / Soligenix, Inc. 1,034,483
2013-01-31 13D/A PRPO / Precipio, Inc. 29,263,131
2012-11-09 13D/A ZIOP / Alaunos Therapeutics Inc 14,930,535
2012-11-01 13D/A SYN / Synthetic Biologics Inc 9,800,768
2012-10-19 13D/A SYN / Synthetic Biologics Inc 6,675,768
2012-10-15 13D FCSC / Fibrocell Science Inc. 232,938,000
2012-08-03 13D/A OGEN / Oragenics, Inc. 5,249,980
2012-06-12 13D OGEN / Oragenics, Inc. 4,392,425
2012-06-06 13D/A HALO / Halozyme Therapeutics, Inc. 19,949,503
2012-02-13 13D/A HALO / Halozyme Therapeutics, Inc. 18,663,816
2012-02-07 13D/A PRPO / Precipio, Inc. 20,263,131
2012-01-25 13D/A ZIOP / Alaunos Therapeutics Inc 11,293,609